Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

4.85

Margin Of Safety %

-14

Put/Call OI Ratio

0.44

EPS Next Q Diff

0.25

EPS Last/This Y

3.36

EPS This/Next Y

1.3

Price

243.01

Target Price

310.53

Analyst Recom

1.55

Performance Q

-16.73

Relative Volume

1.37

Beta

0.4

Ticker: PEN




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04PEN251.060.160.004385
2025-07-07PEN248.310.160.254386
2025-07-08PEN247.80.160.074376
2025-07-09PEN244.310.160.974361
2025-07-10PEN243.620.250.395362
2025-07-11PEN238.040.260.035415
2025-07-14PEN239.180.280.215104
2025-07-15PEN236.30.290.075086
2025-07-16PEN234.340.270.115371
2025-07-17PEN230.180.261.055467
2025-07-18PEN230.260.250.105499
2025-07-21PEN228.890.300.154119
2025-07-22PEN231.920.300.044202
2025-07-23PEN233.640.290.004247
2025-07-24PEN230.230.290.174259
2025-07-25PEN233.260.290.004249
2025-07-28PEN230.120.2911.934285
2025-07-29PEN227.180.381.964631
2025-07-30PEN254.290.612.386829
2025-07-31PEN252.480.440.176065
2025-08-01PEN242.910.440.866093
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04PEN251.0628.4134.43.75
2025-07-07PEN248.2128.4131.23.75
2025-07-08PEN247.8028.4133.03.75
2025-07-09PEN244.3928.4130.83.75
2025-07-10PEN243.8728.4133.03.75
2025-07-11PEN237.9428.4128.43.75
2025-07-14PEN239.3028.4134.53.75
2025-07-15PEN236.4128.4131.13.75
2025-07-16PEN234.4128.4131.83.75
2025-07-17PEN230.1028.4129.93.75
2025-07-18PEN230.2628.4133.53.75
2025-07-21PEN228.8328.4132.13.75
2025-07-22PEN232.0528.4136.03.75
2025-07-23PEN233.3928.4134.63.75
2025-07-24PEN230.1828.3130.83.76
2025-07-25PEN233.1028.3135.83.76
2025-07-28PEN230.3128.3131.13.76
2025-07-29PEN227.1528.3130.93.76
2025-07-30PEN254.2128.3155.83.76
2025-07-31PEN252.277.68.83.72
2025-08-01PEN243.017.62.73.72
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04PEN-16.91-0.544.06
2025-07-07PEN-16.89-0.544.06
2025-07-08PEN-16.89-0.544.06
2025-07-09PEN-16.89-0.544.06
2025-07-10PEN-16.89-0.544.06
2025-07-11PEN-16.89-0.545.06
2025-07-14PEN-17.79-0.555.06
2025-07-15PEN-17.79-0.555.06
2025-07-16PEN-17.79-0.555.06
2025-07-17PEN-17.79-0.555.06
2025-07-18PEN-17.79-0.555.06
2025-07-21PEN-17.65-0.525.06
2025-07-22PEN-17.65-0.525.06
2025-07-23PEN-17.65-0.525.06
2025-07-24PEN-17.65-0.525.06
2025-07-25PEN-17.65-0.524.88
2025-07-28PEN-18.54-0.474.88
2025-07-29PEN-18.54-0.474.88
2025-07-30PEN-18.54-0.474.88
2025-07-31PEN-18.40-0.474.88
2025-08-01PEN-18.29-0.474.85
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.86

Avg. EPS Est. Current Quarter

0.91

Avg. EPS Est. Next Quarter

1.11

Insider Transactions

-18.29

Institutional Transactions

-0.47

Beta

0.4

Average Sales Estimate Current Quarter

340

Average Sales Estimate Next Quarter

361

Fair Value

209.33

Quality Score

95

Growth Score

94

Sentiment Score

96

Actual DrawDown %

30.3

Max Drawdown 5-Year %

-62.6

Target Price

310.53

P/E

64.43

Forward P/E

48.26

PEG

1.54

P/S

7.4

P/B

7.32

P/Free Cash Flow

58.64

EPS

3.77

Average EPS Est. Cur. Y​

3.72

EPS Next Y. (Est.)

5.02

Target Price Estimates Raised

5

Target Price Estimates Lowered

2

Profit Margin

11.54

Relative Volume

1.37

Return on Equity vs Sector %

-12.3

Return on Equity vs Industry %

-6.8

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.04

EBIT Estimation

2.7
Penumbra, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 4500
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, and aspiration pump under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as detachable coils to treat patients with a wide range of neurovascular lesions under the Penumbra SMART COIL and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.
stock quote shares PEN – Penumbra, Inc. Stock Price stock today
news today PEN – Penumbra, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PEN – Penumbra, Inc. yahoo finance google finance
stock history PEN – Penumbra, Inc. invest stock market
stock prices PEN premarket after hours
ticker PEN fair value insiders trading